Ethical considerations of comparing sequential and traditional anti-Helicobacter pylori therapy

Annals of Internal Medicine

Volumn 147, Issue 6, 2007, Pages 434-435

  Graham, David Y ^a   Yamaoka, Yoshio ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR; TINIDAZOLE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CANCER RISK; CLINICAL TRIAL; DRUG EFFECT; DYSPEPSIA; ERADICATION THERAPY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFORMED CONSENT; INTESTINE METAPLASIA; LETTER; MEDICAL ETHICS; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER; SYMPTOMATOLOGY; TREATMENT OUTCOME; METHODOLOGY; NOTE; STANDARD;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; RESEARCH DESIGN;

EID: 34548807525     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-147-6-200709180-00022     Document Type: Letter

References (9)